REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 |
FOR |
MEDSA GROUP LIMITED |
REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 |
FOR |
MEDSA GROUP LIMITED |
MEDSA GROUP LIMITED (REGISTERED NUMBER: 05084053) |
CONTENTS OF THE FINANCIAL STATEMENTS |
For The Year Ended 31 December 2023 |
Page |
Company Information | 1 |
Abridged Statement of Financial Position | 2 |
Notes to the Financial Statements | 4 |
MEDSA GROUP LIMITED |
COMPANY INFORMATION |
For The Year Ended 31 December 2023 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
MEDSA GROUP LIMITED (REGISTERED NUMBER: 05084053) |
ABRIDGED STATEMENT OF FINANCIAL POSITION |
31 December 2023 |
2023 | 2022 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
Investments | 5 |
CURRENT ASSETS |
Stocks |
Debtors |
Cash in hand |
CREDITORS |
Amounts falling due within one year |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
MEDSA GROUP LIMITED (REGISTERED NUMBER: 05084053) |
ABRIDGED STATEMENT OF FINANCIAL POSITION - continued |
31 December 2023 |
In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
MEDSA GROUP LIMITED (REGISTERED NUMBER: 05084053) |
NOTES TO THE FINANCIAL STATEMENTS |
For The Year Ended 31 December 2023 |
1. | STATUTORY INFORMATION |
Medsa Group Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Turnover represents the sale of corporate solutions products and services, excluding value added tax, during the year. |
Turnover is recognised as the right to consideration arises and adjustments are made for accrued and deferred income. |
Tangible fixed assets |
Tangible fixed assets are stated at cost or valuation less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended by management. |
Depreciation is provided at the following annual rates in order to write off each asset its estimated useful life. |
Plant and machinery | - | 25% on reducing balance |
Fixtures and fittings | - | 25% on reducing balance |
Computer equipment | - | 33.33% on cost |
Investments in associates |
Investments in subsidiary and associate undertakings are recognised at cost less impairment. |
Stocks |
Stocks are stated at the lower of cost and estimated selling price, less costs to complete and sell. Cost includes all costs of purchase, including costs to bring stock to its present location and condition. Provision is made for damaged, obsolete and slow-moving stock where appropriate. |
Financial instruments |
The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost, except for investments in subsidiaries and associate undertakings, which are measured at cost less impairment. At the end of each reporting period financial instruments are assessed for evidence of impairment, and changes are recognised in profit or loss. |
Taxation |
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. |
Consideration is given to whether deferred tax should be provided in respect of material timing differences which have not reversed at the balance sheet date. Deferred tax assets are only recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or future taxable profits. |
Current tax assets and liabilities are not discounted and are recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Foreign currencies |
Transactions denominated in foreign currencies are translated into sterling and recorded at the rate of exchange ruling at the date of the transaction. Balances at the year-end denominated in a foreign currency are translated into sterling at the rate of exchange ruling at the balance sheet date. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable are charged to the profit and loss in the period to which they relate. |
MEDSA GROUP LIMITED (REGISTERED NUMBER: 05084053) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
For The Year Ended 31 December 2023 |
2. | ACCOUNTING POLICIES - continued |
Hire purchase and leasing commitments |
Rentals payable under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | TANGIBLE FIXED ASSETS |
Totals |
£ |
COST |
At 1 January 2023 |
Additions |
At 31 December 2023 |
DEPRECIATION |
At 1 January 2023 |
Charge for year |
At 31 December 2023 |
NET BOOK VALUE |
At 31 December 2023 |
At 31 December 2022 |
5. | FIXED ASSET INVESTMENTS |
Information on investments other than loans is as follows: |
Totals |
£ |
COST |
At 1 January 2023 |
and 31 December 2023 | 2,040,245 |
NET BOOK VALUE |
At 31 December 2023 | 2,040,245 |
At 31 December 2022 | 2,040,245 |
Information on loans is as follows: |
Totals |
£ |
At 1 January 2023 |
Additions | 44,993 |
At 31 December 2023 | 1,240,513 |
MEDSA GROUP LIMITED (REGISTERED NUMBER: 05084053) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
For The Year Ended 31 December 2023 |
6. | LEASING AGREEMENTS |
Minimum lease payments under non-cancellable operating leases fall due as follows: |
2023 | 2022 |
£ | £ |
Within one year |
Between one and five years |
In more than five years |
7. | SECURED DEBTS |
The following secured debts are included within creditors: |
2023 | 2022 |
£ | £ |
Bank overdrafts |
Debentures | 2,669,185 | 2,278,705 |
Debenture loan interest | 151,712 | 151,712 |
A charge over all the undertaking, property and assets of the company was created on 6 December 2011 by Lloyds TSB Bank plc to secure all moneys and liabilities due. |
Floating charges have been raised over all the property or undertaking of the company by a director to secure all debenture loan balances and interest due from the company. |
8. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
As at 31 December 2023, a director had loaned the company £2,350,043 (2022 - £2,495,354). The loan attracted interest at 1% over the Bank of England base rate up until 31 December 2013 and the amount due is repayable upon demand. No interest was charged on the loan during the year ended 31 December 2023. As at 31 December 2023 an amount of £656,435 (2022 - £656,435) was owed to a director with regard to accrued interest charges on his loan account. The amounts due are included within Directors' current accounts and Other creditors due after more than one year. |
As at 31 December 2023, a director had debenture loans due from the company of £2,669,185 (2022 - £2,278,705). Interest of £nil (2022 - £nil) has been charged on the loans. As at 31 December 2023 an amount of £151,712 (2022 - £151,712) was owed to a director with regard to accrued interest charges on his debenture loans. |
The debenture loans due and associated interest charges are repayable upon demand however the director has agreed not to request the secured liabilities for a period of twelve months from the date of approval of the balance sheet in order to support the company's continued operation on a going concern basis. The amounts due are therefore included within Debentures and Other creditors due after more than one year. |
9. | RELATED PARTY DISCLOSURES |
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |